Warburg Pincus invests in $50m pharma PIPE
The global private equity firm has agreed to invest $50m in publicly-traded biopharmaceutical company Allos Therapeutics in exchange for 42 percent ownership and two seats on the board of directors.
The global private equity firm has agreed to invest $50m in publicly-traded biopharmaceutical company Allos Therapeutics in exchange for 42 percent ownership and two seats on the board of directors.
Copyright PEI Media
Not for publication, email or dissemination